Abstract We used Affymetrix microarrays to compare gene expression profiles of the metastatic parental breast cancer cell line MDA-MB-435 (435) and the nonmetastatic daughter cell line created by the stable expression of the BReast cancer Metastasis Suppressor 1 (BRMS1) gene in 435 cells, MDA-MB-435-BRMS1 (435/ BRMS1). Analysis of microarray data provided insight into some of the potential mechanisms by which BRMS1 inhibits tumor formation at secondary sites. Furthermore, due to the importance of the microenvironment, we also examined gene expression under different growth conditions (i.e., plus or minus serum). Expression of 565 genes was significantly (adjusted P-value \0.05) altered regardless of in vitro growth conditions. BRMS1 expression significantly increased multiple major histocompatability complex (MHC) genes and significantly decreased expression of several genes associated with protein localization and secretion. The pattern of gene expression associated with BRMS1 expression suggests that metastasis suppression may be mediated by enhanced immune recognition, altered transport, and/or secretion of metastasis-associated proteins. 
Introduction
Breast cancer metastasis suppressor 1 (BRMS1) is one of a growing family of genes termed metastasis suppressors, that block development of metastasis without preventing orthotopic tumor growth [1] [2] [3] . For the most part, the mechanisms by which metastasis suppressors inhibit are not well understood. BRMS1 induces several apparently unrelated phenotypic changes-restoration of homotypic gap junctional intercellular communications [4, 5] , inhibition of NFjB signaling [6] , abrogation of phosphoinositide signaling [7] .
The breadth of BRMS1-induced cellular changes are, in part, explained by its role as a component of core mSin3a:histone deacetylase complexes and interaction with the retinoblastoma tumor suppressor [8] [9] [10] . Thus, BRMS1 is positioned within the cell to regulate expression of a plethora of genes, yet histone deacetylase inhibitors (and by inference, the acetylases and deacetylases themselves) regulate only approximately 2% of known genes [11] . The objective of the current study was to compare gene expression patterns in BRMS1-expressing versus non-expressing human breast carcinoma cells. We hypothesized that insights regarding BRMS1-associated changes, in particular, and perhaps cancer metastasis in general, would be gained by using unbiased genome-wide expression analyses. Our data shows that BRMS1 expression significantly altered genes involved in: (1) immune response; (2) protein transport and localization; and, (3) Golgi structure and function.
Materials and methods
Cell culture and harvest for RNA isolation Cells were cultured in Corning TM T-175 flasks (Corning catalog no. 431080, Fisher Scientific, Santa Clara, CA) in HyQ DMEM high glucose/SF-12 medium (HyClone, Logan, UT) supplemented with 5% fetal bovine serum (FBS) (Atlanta Biologicals, Lawrenceville, GA), 1% nonessential amino acids, 1.0 mM sodium pyruvate and maintained at 37°C with 5% CO 2 in a humidified atmosphere. Cells were passaged using 0.125% trypsin for the parental 435 cells or 2.0 mM EDTA for the daughter 435/ BRMS1 cells in Ca 2+ /Mg 2+ -free Dulbecco's phosphate buffered saline.
After attachment cells were washed with 1· phosphate buffered saline (PBS). Medium was then replaced for one hour with either fresh complete medium containing 10% FBS or complete serum-free medium. After 1 h medium was removed and cells were harvested by washing once with 1· PBS, followed by addition of 10 ml of Trizol 1 (Invitrogen, Carlsbad, CA). Trizol 1 was incubated with cells for 3-5 min at room temperature before thorough rinsing of flask bottom and removal into a 15 ml conical tube. Samples were then frozen at -80°C at least overnight prior to isolation of total RNA. Samples were thawed at room temperature for 60 min. RNA isolation was done by following the Invitrogen protocol except centrifugation steps were done at 3,200 · g for 30 min or 10 min at 2-8°C in place of the ''long'' or ''short'' centrifugation steps in the protocol.
Microarray hybridizations and analyses
Total RNA was submitted to the Utah State University Affymetrix Core Facility for labeling and hybridization. Samples were assessed for quantity on a NanoDrop ND 1000 spectrophotometer and quality using an Agilent (Santa Clara, CA) Bioanalyzer 2100. Samples were labeled using the Affymetrix GeneChip 1 One-Cycle Target Labeling and Control Kit (part # 900493) as described in the Affymetrix Eukaryotic RNA One-cycle cDNA Synthesis and Labeling manual using an MJ Research DNA Engine Tetrad 2 thermocycler 1 (Bio-Rad Laboratories, Hercules, CA). Hybridization was performed using a GeneChip Hybridization Oven 640 1 (Affymetrix, Santa Clara, CA). Washing and staining was performed using an Affymetrix GeneChip Fluidics Station 650 1 then chips were scanned using an Affymetrix GeneChip Scanner 3000 1 and images interpreted and monitored using GCOS version 1.2.
Briefly, single-then double-stranded cDNA was synthesized using a T7-oligo primer followed by sample purification. Synthesis of biotin-labeled cRNA proceeded using clean double-stranded cDNA and the Affymetrix IVT labeling kit. Labeled cRNA was purified, quantified and fragmented prior to addition to pre-warmed U133 plus 2.0 chips. Following overnight hybridization, chips were washed and subjected to stain solution, then washed to remove excess stain. After scanning, images were assessed for quality using default metric settings. Both raw and quality controlled data were received for each sample.
Data was analyzed by standard methods using R [12] and Bioconductor [13] (open source program; http:// www.bioconductor.org) for all statistical analyses. The eight Affymetrix Gene Chip array raw data files were normalized using the robust multi-array analysis (RMA) procedure in Bioconductor's affy package [14] , which includes background correction, quantile normalization, and probe set summary. Using Bioconductor's limma package [15] , a linear model was fit to the normalized data and contrasts tested for a cell line-media interaction and cell line and media main effects. The top 750 significant cell line effect probe sets were selected to generate a working gene list, which corresponded to an FDR-adjusted P-value cutoff of P \ 0.05 and B (log odds) cutoff of 0.
The working list of significant probe sets was used as the basis for performing a functional over-representation analysis using mappings to Gene Ontology (GO) [16] . The working list of significant probe sets was first converted to a list of unique Entrez Gene [17] identifiers. Probe sets were then matched to Entrez Gene entries, and the genes were mapped to their representative GO identifiers, as well as all connected GO ancestors. Using a hypergeometric P-value, each GO identifier was evaluated for overrepresentation in the list of significant genes. Due to the nature of the hypergeometric calculation and its testing of many dependent hypotheses, interpretation of this P-value is not straightforward. In addition, GO identifiers with few annotated genes tend to show artificially small P-values. We therefore used the developer's suggested criteria and focused our attention on GO identifiers having a small P-value (P \ 0.05) and at least 10 member genes as significantly over-represented [18] .
The expression patterns of genes found in selected overrepresented GO terms were plotted on heat maps with the gplots package [19] using Euclidean hierarchical clustering on the genes. Replicates and multiple probe sets when present for a given gene were averaged for display purposes.
qRT-PCR Total RNA was thawed on ice and aliquots were diluted to provide standards at 100, 50, 10, 0.1 and 0.05 ng final concentrations. The hypoxanthine guanine phosphoribosyl transferase (HPRT) gene was used as the standard. Samples were probed for relative copy number using a start concentration of 10 ng of total RNA. Samples were prepared using TaqMan primers and probe sets (GeneScript, Inc., Scotch Plains, NJ) and the Qiagen (Valencia, CA) QuantiTect Probe RT-PCR kit according to the directions. Samples were processed and recorded using a M.J. Research Opticon 2 system. Data analyses were performed using Opticon 2 software.
Results
The analytical approach used in this study is outlined in a flow chart (appendix, Fig. A.1) . RNA was isolated from parental 435 and 435/BRMS1 cells cultured for one hour in serum-containing or serum-free growth conditions, quantified and hybridized to Affymetrix human U133 plus 2.0 chips. Normalization and analysis of the raw data files from the microarray analyses was performed (see materials and methods) and a linear model was then fit to the normalized data and contrasts tested for cell line or media effects. No media effects were identified (effects specific to the presence or absence of serum), but some gene chip probe sets were found to have a significant (adj. P-value \0.05) cell line effect.
The differentially expressed gene list generated using this approach reveals patterns or groups of genes whose expression is changed as a result of BRMS1 expression in the 435 cell line. From our differentially expressed gene list the 40 genes whose expression showed the greatest fold change induction were compiled (Table 1) . This list contains genes in descending order by fold change that have been implicated in the immune response, signal transduction, metabolism, transcription, cytoskeleton, Golgi apparatus, and transport. The 40 genes whose expression showed the greatest fold change repression are shown in Table 2 . These genes have been associated with transport, cell adhesion, signal transduction, metabolism, cell proliferation, cytoskeleton, and extracellular matrix.
Our gene lists provide some insight into the effect of BRMS1 expression, but information in this format fails to uncover the overall biological relevance of the transcriptional changes that lead to a block in metastasis resulting from BRMS1 expression. A statistically sound method for summarizing significant gene lists into the biological processes they represent has been developed by Gentleman [18] . This technique, known as over-representation analysis, was applied to the data.
The working list of significant probe sets was used as the basis for performing a functional over-representation analysis using mappings to GO. This technique helps to highlight the overall processes that our list of significant genes represents, and offers an effective method to reveal the biological relevance of transcriptional changes which may not be apparent examining the list on a gene-by-gene basis. The results of functional over-representation analysis are shown as directed acyclic graphs (DAG) with each graph node representing a GO term. GO terms found to be significantly over-represented were colored according to the collective trend for induction or repression among the genes at that GO term. Red indicates that genes at that node show collective mean induction in 435/BRMS1 cells, while blue indicates collective mean repression. Nodes not colored are not significantly over-represented, but are included to maintain connectivity. Significantly overrepresented GO terms within the biological process (BP) GO category are shown (Fig. 1A) . Some of the most highly over-represented BP GO terms include immune response (Fig. 1B ) and protein localization (Fig. 1C) . For the cellular component (CC) GO category (data not shown), the most notable over-representation was found at the Golgi apparatus.
To elucidate which nodes contribute to over-representation within the general GO term of immune response an expansion of the DAG of BP GO terms with both ancestor and child terms is shown in more detail (Fig. 2A) . The function depicted in the expansion proceeds from general in the bottom nodes to very specific in the top nodes ( Fig. 2A) . To visualize expression of individual genes expanded heat maps were created for specific BP GO terms (appendix Figs. A.2-A.4). Figure 2B depicts a combination figure of DAG representation for individual genes which fall within child nodes of the ''immune response'' node (j in Fig. 2A ) combined with the heat map expression intensities for each. The full heat map of the expression of the genes within the BP GO term immune response is shown (appendix Fig. A.2) . A more detailed list of genes significantly (adj. P-value \0.05) induced within the immune response BP GO term is shown in tabular from in the appendix (appendix, Table 1 ). Of the genes most highly induced in 435/BRMS1 cells are several encoding major histocompatibility complex (MHC), class I and II proteins, including: HLA-DQB1, HLA-DRB1, HLA-DRB5, HLA-DMB, HLA-DQA1, HLA-DPA1, HLA-DRA, HLA-DRB4, HLA-DMA, C1S, HLA-B, HLA-C, and HLA-F.
Our analyses also uncovered changes in the expression of genes associated with protein localization/transport (Fig. 3A and B) . Significant (adj. P-value \0.05) genes were found to be associated with the BP GO term protein localization, as well as child GO terms intracellular protein transport, protein secretion, protein transport, and establishment of protein localization (Fig. 3A) . A more detailed expression profile for individual genes identified in the protein localization BP GO term is shown in the full heat map (appendix Fig. A.3) .
For the protein localization GO term, expression of several genes is repressed coincident with BRMS1 expression including: RBP1, RAB1A, APBA2BP, TIMM22, DNAJC1, RAB8B, SNX1, SSR3, SNX5, and RAB27A. Genes whose expression is induced as a result of BRMS1 expression include: SEC23IP, SEC3L1, SYTL2, COG1, NUP98, COPZ2, CD74 (2), AP1S2, A2M, SCG2, FYB, AP1G2, TGFB1, TLK1, GNAS, and PEX13.
The genes significantly (adj. P-value \0.05) altered in 435/BRMS1 cells identified by over-representational analysis to be involved in the Golgi apparatus GO node under Cellular Component are shown as a heat map (appendix Fig. A.4) . Those whose expression is significantly (adj. P-value \0.05) repressed coincident with BRMS1 expression include: D4ST1, PIK4CA, ATP7A, ST6GALNAC2, APBA2BP, RAB1A, B3GNT1, LARGE, GOLGA8A, AP1G2, ST6GALT1, SNX1, and B4GALT1. Genes whose expression is significantly (adj. P-value \0.05) induced as a result of BRMS1 expression include: COG1, SEC23IP, PSENEN, AP1S2, COPZ2, BACE1, BICD1, VAMP4, IL15, and HS3ST3A1.
In an effort to test the validity of the microarray data that we obtained, we used quantitative real-time polymerase chain reaction (qRT-PCR) as a second technique to examine changes in gene expression. Five genes from our differentially expressed gene list were selected at random for confirmation using qRT-PCR. TaqMan primers and probes were obtained (GeneScript or Applied Biosystems, Inc.) for BRMS1, Endothelin converting enzyme 2 (ECE2), Ectonucleotide pyrophosphatase phosphodiesterase 2 (ENPP2), Abl-interacting protein 2 (ABI2) and Caspase 1 (CASP1). qRT-PCR was performed using a one-step protocol. Under our experimental conditions only amplification of ECE2 produced signal below our lowest control making a reasonable assessment of its expression level in either cell type inconclusive. All other products from amplification (appendix, Fig. A.5 ) clearly corroborated our analyses of the microarray data.
Discussion
Metastasis is a complex, multi-step event involving cellular processes such as protein transport, cytoskeletal rearrangements and signal transduction. While the amino acid sequence of BRMS1 provided minimal clues regarding function, identification of proteins with which BRMS1 interacts led to the understanding that BRMS1 is involved in transcriptional machinery. Specifically, the BRMS1 protein is a component of multiple mSIN3a:histone deacetylase complexes. Because these complexes regulate chromatin structure, they have the potential to influence gene expression throughout the genome. To better understand BRMS1 function, in particular, its role in regulating gene expression, a genomewide unbiased expression study was initiated.
Using Affymetrix platforms coupled with robust informatic analyses, we found that BRMS1 re-expression selectively changed expression of certain categories of genes, especially MHC Class I and II and molecules involved in protein transport and secretion. The patterns of gene expression change provide insights into the steps of metastasis influenced by BRMS1 expression.
The most dramatically over-represented gene ontology designation was host immune system, which is a complicated compilation of molecules and events involved in immune response (Table 1 , Fig. 2 ; appendix Table 1 , Fig. 2) . In response to BRMS1 expression, the expression of several immune response genes was altered including: MHC class I, MHC class II, interleukins, interferoninduced, interferon-induced protein with tetratricopeptide repeats, CD antigens and several others with roles in processing or transport of antigens.
Previous studies have shown that some MHC class I genes are not expressed in certain cancers, which may alter the immune response [20] [21] [22] . Altered expression of MHC, class I and II molecules has been described in metastatic lesions from breast tumors [23] [24] [25] and breast cancer lines [26] . Notably, the expression of MHC class I molecules on cancer cells has an important role in the cytotoxic T-lymphocyte (CTL)-mediated immune response [27] , and up-regulation of MHC class I genes could provide opportunities for CTL's to recognize and destroy cancer cells [28] . However, a cause and effect relationship has not been clearly established. On a related note, the tumor suppressor pRb appears to be required for up-regulation of some MHC, class II genes [29, 30] . Therefore, some similarity may exist in the mechanism of action of tumor suppressors and metastasis suppressors. Additionally, involvement of pRB may be linked to this effect by BRMS1 as the two are known to interact.
MHC, class II classical molecules, HLA-DPA, -DPB, -DQA, -DQB, -DRA and -DRB, are normally expressed on professional Antigen Presenting Cells (APC'S) and a few other types of cells. These molecules present peptides derived from proteins degraded in endosomes. Earlier studies suggest that changes in expression of MHC, class II molecules may influence tumor cell evasion of immune surveillance favoring metastatic disease [31, 32] . MHC class II genes were found repressed in highly metastatic cells [30] . Induction of MHC class I and II genes may be one mechanism by which 435/BRMS1 cells are kept at low populations, by triggering an immune response that eliminates them in lung and bone.
In addition to immune response gene expression changes, GO analyses revealed two other over-represented GO categories, the BP GO term protein localization and CC GO term Golgi apparatus. Reciprocally, one is dependent on the other-the structure of the Golgi apparatus is dependent upon protein localization, and appropriate protein localization is dependent upon the Golgi apparatus for transportation.
The secretory pathway of eukaryotic cells is a highly complex bidirectional system which includes the endoplasmic reticulum, the cis-, medial-, and trans-Golgi, the late endosome, the lysosome/vacuole, and the plasma membrane. Proteins transported in this elaborate system are first synthesized at the endoplasmic reticulum (ER) membrane where they remain in the membrane or are injected into the lumen of the ER. Proteins packaged into lipid vesicles are then transported in an anterograde direction to more distal sites in the pathway via a series of vesicle budding, docking and fusion events. Alternatively, proteins can be retained in secretory compartments or retrieved to a more proximal compartment via a retrograde trafficking process.
The processes of lipid vesicle fission (breaking off the donor membrane), transport, and fusion (with the acceptor membrane) are complex and involve a number of membrane associated and transmembrane proteins. Uncovered in this study were genes representing membrane associated proteins such as vesicle-associated membrane protein 4 (Vamp4), COPZ2, sec3L1, sec23IP, adaptor-related protein complex subunits (AP1G2 and AP1S2), as well as those genes encoding proteins known to cycle from the cytosol to a membrane (vesicle, Golgi, endosome, or plasma membrane).
Other gene products known to have a role in regulation of vesicle-mediated protein trafficking that are found localized to membranes or in the cytosol include the small monomeric GTPases Rab1a, Rab8b, and Rab27a which have been implicated in vesicle formation, uncoating and docking [33] [34] [35] . Notably, Rab27a and the synaptotagminlike 2 (SYTL2) protein are involved in melanosome transport [36] . The sorting nexins (SNX1 and SNX5) which are known to bind phosphoinositides (via PX domains) associate with the retromer complex and regulate protein transport at the endosome [37, 38] . Also a regulator of vesicle-mediated protein trafficking and phosphoinositide metabolism is the PtdIns 4-kinase (PIK4CA) with a role in protein transport from the Golgi to the plasma membrane [39, 40] . Altogether, the data strongly suggest that the expression of BRMS1 alters exocytic protein trafficking, with changes in genes that encode proteins associated with the ER, Golgi, and endosomes. Importantly, changes in proteins associated with Golgi function would have profound affects on protein transport.
Several genes whose protein products have important roles in protein and lipid modification within the Golgi compartments were also altered. Those genes include glycosyltransferases (e.g., LARGE), galactosyltransferase (B4GALT1), N-acetylglucosaminyltransferase (B3gnt1), sialyltransferase (ST6GALNAC2), and sulfotransferase (D4ST1). The decrease in expression of these genes may reflect an overall reduction in post-translational protein modification prior to transport, or be specific to a subset of proteins and lipids.
Two other cellular attributes that seem to be altered in the BRMS1-expressing cells are the cytoskeletal-related genes and cell-adhesion related genes. Several genes whose expression is changed very likely affect how cell-to-cell and cell-to-extracellular matrix interactions occur. Notably, we also observed significant (adj. P-value \0.05) gene expression changes in connexin 32 (full data set on web site) that was previously implicated in metastasis and associated with BRMS1 expression [5] .
Altogether, what do these results tell us about the mechanism by which metastasis can be suppressed? The inherently simple design of this study was to express a single metastasis suppressor gene, BRMS1, in order to gain insight into potential transcriptional changes that enable switching a highly metastatic cell line to a nonmetastatic cell line. The results strongly suggest that BRMS1 suppression of metastasis is in part accomplished by altering the host immune response, intracellular protein transport and Golgi structure and function. In addition to these potentially coordinated effects, changes in expression of numerous genes involved in signal transduction, cell adhesion, cytoskeletal architecture, cell proliferation and metabolism (see supplementary material for summary gene list) were observed in BRMS1-expressing cells. The breadth of changes is consistent with the observed biology.
Many of the changes observed in gene expression could potentiate altering of the microenvironment of micrometastases via changes in protein transport, secretion, or extracellular matrix affects. Alternatively, observed changes may alter how the non-metastatic 435/BRMS1 cells are able to respond to the stimuli encountered in the microenvironment. That is, the non-metastatic cells respond differently to growth factor mediated signaling, alter their cytoskeleton or that their cell adhesion properties are altered compared to the metastatic cells. While this study provides processes and genes that should be evaluated, follow-up studies carefully examining cause and effect of individual genes or sets of genes and how these modulate metastasis are necessary. Color key is shown at top left and represents the log(2) expression intensity for the average of the probe sets for the specified gene determined to be significantly altered in our data. Cyan color indicates lower relative expression and magenta indicates higher relative expression. If more than one probe set for a given gene was determined to be significant, they were averaged together prior to heat mapping and the number of probe sets is indicated in parentheses to the right of the gene symbol on the map. The presence or absence of fetal bovine serum (FBS) in the samples from each cell line is indicated at the bottom of the map Fig. A.2 Heat map of significant genes within the biological process (BP) Gene Ontology (GO) term immune response. Color key is shown at top left and represents the log(2) expression intensity for the average of the probe sets for the specified gene determined to be significantly (adj. P-value \0.05) altered in our data. Cyan color indicates lower relative expression and magenta indicates higher relative expression. If more than one probe set for a given gene was determined to be significant, they were averaged together prior to heat mapping and the number of probe sets is indicated in parentheses to the right of the gene symbol on the map. The presence or absence of fetal bovine serum (FBS) in the samples from each cell line is indicated at the bottom of the map Fig. A.4 Heat map of significant genes within the cellular component (CC) Gene Ontology (GO) term Golgi apparatus. Color key is shown at top left and represents the log(2) expression intensity for the average of the probe sets for the specified gene determined to be significantly altered in our data. Cyan color indicates lower relative expression and magenta indicates higher relative expression. If more than one probe set for a given gene was determined to be significant, they were averaged together prior to heat mapping and the number of probe sets is indicated in parentheses to the right of the gene symbol on the map. The presence or absence of fetal bovine serum (FBS) in the samples from each cell line is indicated at the bottom of the map 
